Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10Stomach Neoplasms 4Colonic Neoplasms 3Rectal Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Postoperative Complications 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Locally Advanced Colorectal Cancer 1HER-2 Positive Gastric Cancer 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Colon Cancer Liver Metastasis 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Locally Advanced Colorectal Cancer × Oxaliplatin × Clear all
NCT06550453 2024-11-12

Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer

Xijing Hospital

Phase 4 Recruiting
20 enrolled
Gastrointestinal

Locally Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡